Press Release Details

View all news

Bruker Corporation to Present at Investor Conferences

June 04, 2018

BILLERICA, Mass., June 4, 2018 /PRNewswire/ -- Bruker Corporation (NASDAQ: BRKR) announced today it will present at the following conferences:

Bruker Corporation Logo

Jefferies 2018 Global Healthcare Conference, New York, NY
Thursday, June 7, 2018, at 8:30 a.m. Eastern Time
Frank Laukien, President and Chief Executive Officer
Juergen Srega, President, Bruker CALID Group

William Blair 38th Annual Growth Stock Conference, Chicago, IL
Wednesday, June 13, 2018, at 8:40 a.m. Central Time
Frank Laukien, President and Chief Executive Officer
Gerald Herman, Interim Chief Financial Officer

A live audio webcast of Bruker's Jefferies 2018 Global Healthcare Conference presentation will be available on the Investor Relations section of the Company's Web site at A replay of the presentation will be posted on the Bruker Corporation Investor Relations website after the event and will be available for 30 days following the presentation.

About Bruker Corporation (NASDAQ: BRKR)

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology. For more information, please visit:

Contact :                                                          
Miroslava Minkova                                                                                           
Head of Investor Relations
Bruker Corporation                                                                   
T: +1 (978) 663 – 3660, ext. 1479                                                                                    


Cision View original content with multimedia:

SOURCE Bruker Corporation

Categories: Press Releases
View all news